Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

MGI Pharma to copromote rheumatology product with Pharmacia & Upjohn

July 19, 1999

Inhibitors of caspases undergo joint development at Warner-Lambert and BASF

July 19, 1999

New label sought for Enbrel in early, active RA

July 16, 1999

AdProTech presents data on its membrane-active complement inhibitor

July 16, 1999

CSAID from Italfarmaco prevents de novo formation of B1 receptors

July 15, 1999

New series from Novo Nordisk useful for pain, inflammation, NIDDM, etc.

July 15, 1999

TT-232, a new somatostatin analogue, effective against neurogenic and non-neurogenic inflammation

July 14, 1999

Novel pyridazines from Kowa inhibit cytokine production

July 14, 1999

New MMP inhibitors, their preparation and use described by Pfizer scientists

July 13, 1999

Connetics enters licensing and development agreement with Paladin for ConXn

July 12, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...